New Covid-19 therapy drug candidates together with Anixa Biosciences Inc.
21 December 2020
OntoChem and its partner Anixa Biosciences Inc. have verified that one of their recently discovered drug-like, small molecule compounds is similar in potency to remdesivir, the only approved antiviral drug against SARS-Cov-2. Using OntoChem’s semantic technologies OntoChem and Anixa had previously identified multiple compounds that could disrupt the function of a viral enzyme called an endoribonuclease (also known as Non-Structural Protein-15, or NSP-15).
See also Anixa Press release.
